CuromeBiosciences
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of HK-660S in the Treatment of Primary Sclerosing Cholangitis (NCT06975150) | CuromeBiosciences | 2025-08-18 |
| Evaluation of the Safety and Efficacy of HK-660S in Patients With Primary Sclerosing Cholangitis (NCT05866809) | CuromeBiosciences | 2021-10-28 |
Track CuromeBiosciences automatically
Every clearance here is in the API, with alerts when new ones post.